Lakefront Biotherapeutics revenue and financials

LKFT · Euronext Amsterdam · EUR

Compare Lakefront Biotherapeutics
€30.38Change from previous close: −1.62%Absolute change: −€0.50

Close · November 20, 2026

In the fiscal year ended December 2025, Lakefront Biotherapeutics reported revenue of €1.11B (+303.50% year over year). Net income was €320.88M, a net margin of 28.9%.

Annual revenue · 2025: €1.11B
  1. €151.61M2016
  2. €155.92M2017
  3. €317.85M2018
  4. €834.9M2019
  5. €478.05M2020
  6. €234.38M2021
  7. €241.25M2022
  8. €239.72M2023
  9. €275.65M2024
  10. €1.11B2025

Fiscal year ending in December. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
+303.50%
2025 vs 2024
Net income growth
+333.15%
2025 vs 2024
Net margin
28.9%
2024: 26.9%

How Lakefront Biotherapeutics is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Income statement · Annual
Item2025202420232022202120202019201820172016
Total revenue1,112276240241234478835318156152
Cost of revenue48937024127032152442032321972.0
Gross profit623-94.7-1.6-28.5-86.1-45.6415-5.0-62.679.6
Selling, general and administrative14113313113913218597.039.827.223.5
Research and development459335241270—————67.6
Operating income535-187-85.1-131-172-179369-44.8-89.8-11.5
EBIT535-187-85.1-131-172-179369-44.8-89.8-11.5
EBITDA568-153-41.5-65.5-163-171374-40.4-86.2-8.2
Interest expense1.00.91.86.911.69.41.30.80.90.0
Pre-tax income301-3.15.6-70.8-119-310149-29.2-11654.2
Income tax-18.6-1.89.60.61.41.2-0.20.10.20.2
Net income32174.1212-218-103-305150-29.3-11654.0
Net income to common shareholders319-1.3-4.0-71.4-121-311149-29.3-11654.0
Basic EPS4.85-0.02-0.06-1.09-1.84-4.782.58-0.56-2.341.18
Diluted EPS4.85-0.02-0.06-1.09-1.84-4.782.47-0.56-2.341.14
Average shares (basic)65.965.965.965.765.565.157.652.149.545.7
Average shares (diluted)65.965.965.965.765.565.160.152.149.547.3

Companies in the group: same industry, similar size